A Blockbuster Drug Gains Approval
26798
Early yesterday evening, Biogen IDEC (Nasdaq: BIIB) and Elan (NYSE: ELN) announced that Tysabri had been approved by the FDA for the treatment of multiple sclerosis (MS).
560221
J&J gains pediatric approval of its antipsychosic drug.
558052
An advisory panel recommends approval of a new HIV drug that blocks one key element.
594161
Genzyme announces positive study results with a recently acquired drug.
411375
GlaxoSmithKline Plc  won U.S. approval for a once-a-day breast cancer pill on Tuesday that the drugmaker hopes will launch a new era for its oncology business.
253298
The drug company pushes on after the Enhance trials.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
32747
Swiss pharmaceutical maker Novartis AG said Tuesday it has received U.S. approval for the hypertension drug Tekturna &#151; a potential blockbuster that has shown the ability to lower blood pressure more effectively than common treatments.
321841
The Food and Drug Administration yesterday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
577156
The Global Aids Alliance welcomes the approval of a generic Aids treatment by the US drug regulator.
75091
The world's largest generics maker continues to post strong growth by bedeviling Big Pharma.
573459
A key study of its lead drug proceeds faster than expected.
62771
The FDA's approval of Fentora comes just in time for the drug company.
227772
The pharmaceutical sells European rights to a promising asthma drug.
738382
The drug maker is poised to speed past its rivals.
686027
Sepracor Inc. won a long-awaited approval to sell its new prescription sleep aid, a drug that may help push the money-losing company to a profit.
673366
Swiss pharmaceutical maker Novartis AG said yesterday it has received US approval for the hypertension drug Tekturna -- a potential blockbuster that has shown the ability to lower blood pressure more effectively than common treatments.